Effect of Nasal Steroid in the Treatment of Anosmia Due to COVID-19 Disease
NCT04569825
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
UNKNOWN
Status
250
Enrollment
OTHER
Sponsor class
Conditions
Clinical Trial
Interventions
DRUG:
Ophtamesone
Sponsor
University Of Anbar